QuantaMatrix Inc. (KOSDAQ:317690)
South Korea · Delayed Price · Currency is KRW 4,015.00
+65.00 (1.65%)
At close: Mar 27, 2026
QuantaMatrix Revenue
QuantaMatrix had revenue of 979.63M KRW in the quarter ending September 30, 2025, with 51.47% growth. This brings the company's revenue in the last twelve months to 3.35B, down -10.58% year-over-year. In the year 2024, QuantaMatrix had annual revenue of 2.50B, down -19.91%.
Revenue (ttm)
3.35B
Revenue Growth
-10.58%
P/S Ratio
24.14
Revenue / Employee
n/a
Employees
n/a
Market Cap
80.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.50B | -620.82M | -19.91% |
| Dec 31, 2023 | 3.12B | 1.83B | 142.47% |
| Dec 31, 2022 | 1.29B | 736.16M | 133.90% |
| Dec 31, 2021 | 549.77M | -1.14B | -67.46% |
| Dec 31, 2020 | 1.69B | 877.94M | 108.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 102.75B |
| DRGEM | 102.75B |
| JPI Healthcare | 52.79B |
| L&K Biomed | 38.92B |
| Hironic | 33.18B |
| SELVAS Healthcare | 29.79B |
| Remed | 24.50B |
| Neofect | 16.05B |